11/13/2012 – Opexa Receives Clinical Trial Approval from Health Canada for Novel T-Cell Therapy

[at noodls] – Opexa Receives Clinical Trial Approval from Health Canada for Novel T-Cell Therapy Abili-T Clinical Trial Targeting Expansion to Canada; Non-proprietary Name Granted by USANC THE WOODLANDS, Texas – (November … more

View todays social media effects on OPXA

View the latest stocks trending across Twitter. Click to view dashboard